These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32670862)

  • 41. Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.
    Grbčić P; Tomljanović I; Klobučar M; Kraljević Pavelić S; Lučin K; Sedić M
    Biochem Biophys Res Commun; 2017 Jun; 487(4):782-788. PubMed ID: 28433634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression.
    Yuza K; Nakajima M; Nagahashi M; Tsuchida J; Hirose Y; Miura K; Tajima Y; Abe M; Sakimura K; Takabe K; Wakai T
    J Surg Res; 2018 Dec; 232():186-194. PubMed ID: 30463717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
    Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
    Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation and function of sphingosine kinase 2 in diseases.
    Song DD; Zhou JH; Sheng R
    Histol Histopathol; 2018 May; 33(5):433-445. PubMed ID: 29057430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging.
    Liu S; Du Y; Ma H; Liang Q; Zhu X; Tian J
    Cancer Lett; 2019 Jul; 453():74-83. PubMed ID: 30928380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma.
    Suemura S; Kodama T; Myojin Y; Yamada R; Shigekawa M; Hikita H; Sakamori R; Tatsumi T; Takehara T
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
    Jo SK; Bajwa A; Ye H; Vergis AL; Awad AS; Kharel Y; Lynch KR; Okusa MD
    Kidney Int; 2009 Jan; 75(2):167-75. PubMed ID: 18971925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma.
    Zheng A; Chevalier N; Calderoni M; Dubuis G; Dormond O; Ziros PG; Sykiotis GP; Widmann C
    Oncotarget; 2019 Dec; 10(66):7058-7070. PubMed ID: 31903165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
    Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
    Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    Eresch J; Stumpf M; Koch A; Vutukuri R; Ferreirós N; Schreiber Y; Schröder K; Devraj K; Popp R; Huwiler A; Hattenbach LO; Pfeilschifter J; Pfeilschifter W
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):653-661. PubMed ID: 29392309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
    Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
    Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.
    Parikh ND; Singal AG; Hutton DW
    Cancer; 2017 Oct; 123(19):3725-3731. PubMed ID: 28662266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sphingosine 1-phosphate regulates proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells via syndecan-1.
    Zeng Y; Liu X; Yan Z; Xie L
    Prog Biophys Mol Biol; 2019 Nov; 148():32-38. PubMed ID: 29180036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells.
    Adamiak M; Chelvarajan L; Lynch KR; Santos WL; Abdel-Latif A; Ratajczak MZ
    Oncotarget; 2017 Sep; 8(39):65588-65600. PubMed ID: 29029455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sphingosine-1-Phosphate Inhibition Increases Endoplasmic Reticulum Stress to Enhance Oxaliplatin Sensitivity in Pancreatic Cancer.
    Gao Z; Janakiraman H; Xiao Y; Kang SW; Dong J; Choi J; Ogretmen B; Lee HS; Camp ER
    World J Oncol; 2024 Apr; 15(2):169-180. PubMed ID: 38545484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma.
    Liu J; Liu Y; Meng L; Liu K; Ji B
    Oncol Rep; 2017 Aug; 38(2):899-907. PubMed ID: 28627705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Essential Role of Sphingosine Kinase 2 in the Regulation of Cargo Contents in the Exosomes from K562 Cells.
    Mohamed NNI; Okada T; Kajimoto T; Nakamura SI
    Kobe J Med Sci; 2018 May; 63(4):E123-E129. PubMed ID: 29955024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
    Asumda FZ; Campbell NA; Hassan MA; Fathi R; Vasquez Rico DF; Kiem M; Vang EV; Kim YH; Luo X; O'Brien DR; Buhrow SA; Reid JM; Moore MJ; Ben-Yair VK; Levitt ML; Leiting JL; Abdelrahman AM; Zhu X; Lucien F; Truty MJ; Roberts LR
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
    Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
    BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.